Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
BOHEMIA, N.Y., Nov. 14, 2016 -- For the three months ended September 30, 2016, Scientific Industries Inc. (OTCBB:SCND) reported a net loss of $48,800 ($.03 loss per basic share) on net sales of $1,559,100, compared to a net loss of $60,100 ($.04 loss per basic share) on net sales of $1,444,500 for the three months ended September 30, 2015.
During the same period, revenues increased by $114,600. The increase in revenues was primarily a result of a $193,800 increase in benchtop laboratory equipment sales offset by decreases in sales of catalyst research instruments, and bioprocessing revenues of $75,500 and $3,700, respectively.
The backlog for catalyst research instruments at the end the current year quarter was approximately $1,167,000 compared to $2,944,000 at the end of last year’s same quarter. The Company expects to ship the majority of its current backlog during fiscal year 2017.
About Scientific Industries
Scientific Industries designs, manufactures, and markets a variety of laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and balances; produces and sells customized catalyst research instruments and the research, development and production of bioprocessing systems and methods. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies, and medical device manufacturers.
“Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company’s Securities and Exchange Commission reports, including our annual report on Form 10-K.”
Phone: 888-850-6208 Fax: 631-567-5896 [email protected] www.scientificindustries.com
